Subscribe
Logo small
Search

AOTMiT: The Transparency Council will evaluate drugs in diabetology, cardiology and oncology, among others

MedExpress Team

Medexpress

Published Jan. 15, 2025 09:51

AOTMiT: The Transparency Council will evaluate drugs in diabetology, cardiology and oncology, among others - Header image
Źródło: AOTMiT
On Monday, January 20, the next meeting of the AOTMiT Transparency Council.

The agenda includes:

  1. Preparation of a position paper on the evaluation of the drug Forxiga (dapagliflozinum) for the indication: type 2 diabetes.
  2. Preparation of a position paper on the evaluation of the drug Verzenios (abemaciclibum) under the drug program B.9.FM. "Treatment of patient...

    Content locked

    To gain access to the complete English section of the Medexpress.pl, kindly reach out to us at english@medexpress.pl.

    If you already have an account, please log in

Szukaj nowych pracowników

Dodaj ogłoszenie o pracę za darmo

Lub znajdź wyjątkowe miejsce pracy!